Funded by grants SAF2006-00647 and SAF2007-60780 and ACOMP 09/212. S.M. was the recipientof an EACR training and travel fellowship award, and a CSIC-I3P pre-doctoral fellowship/contract. MicroRNAs (miRNAs) are an emerging class of non-coding endogenous RNAs involved in multiple cellular processes, including cell differentiation. Treatment with Retinoic Acid (RA) results in neural differentiation of neuroblastoma cells. We wanted to elucidate whether miRNAs contribute to the gene expression changes induced by RA in neuroblastoma cells, and whether miRNA regulation is involved in the transduction of the RA signal. We show here that RA treatment of SH-SY5Y neuroblastoma cells results in profound changes in the expression pattern of miRNAs. Up to 42 different miRNA species significantly changed their expression (26 upregulated and 16 downregulated). Among them, the closely related miR-10a and -10b showed the most prominent expression changes. Induction of miR-10a and -10b by RA also could be detected in LA-N-1 neuroblastoma cells. Loss of function experiments demonstrated that miR-10a and -10b are essential mediators of RA-induced neuroblastoma differentiation and of the associated changes in migration, invasion, and in vivo metastasis. In addition, we found that the SR-family splicing factor SFRS1 (SF2/ASF) is a target for miR-10a -and -10b in HeLa and SH-SY5Y neuroblastoma cells. We show here that changes in miR-10a and -10b expression levels may regulate SFRS1-dependent alternative splicing and translational functions. Taken together, our results give support to the idea that miRNA regulation plays a key role in RA-induced neuroblastoma cell differentiation. The discovery of SFRS1 as direct target of miR-10a and -10b support the emerging functional interaction between two post-transcriptional mechanisms, microRNAs and splicing, in the neuronal differentiation context. RT-qPCR analysis of SFRS1 mRNA levels in same conditions. The graph shows expression levels relative to that of RA untreated, NC-premiR transfected cells (mean ± SD of a triplicate experiment)..
A-G. Experimental reduction of miR-10a and10b levels impaired gene expression changes associated with RA-induced differentiation (A-G). RT-qPCR analysis of the mRNA levels of NTRK2 (trkB, A), RET (B), GAP43 (C), ENO2 (neuron-specific enolase, D), ID1 (E), ID2 (F) and ID3 (G). mRNA expression levels after RA treatment of SH-SY5Y cells transfected with anti-miR-10a , -10b or negative control (NC) anti-miR.

A-C. Western blot analysis of the protein levels for ID2 (A), and the neuronal markers Neurofilament medium polypeptide (NFEM, B) and
RT-qPCR analysis of SFRS1 mRNA levels in same conditions. The graph shows expression levels relative to that of RA untreated, NC-premiR transfected cells (mean ± SD of a triplicate experiment)..
